Patients reported that Miebo significantly reduced overall symptoms severity at the primary endpoint of change from baseline ...
The novel nitric oxide-donating bimatoprost eye drop is being clinically developed for the lowering of IOP in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback